112 related articles for article (PubMed ID: 38554328)
21. External validation of an
Mori M; Deantoni C; Olivieri M; Spezi E; Chiara A; Baroni S; Picchio M; Del Vecchio A; Di Muzio NG; Fiorino C; Dell'Oca I
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1329-1336. PubMed ID: 36604325
[TBL] [Abstract][Full Text] [Related]
22. Impact of radiogenomics in esophageal cancer on clinical outcomes: A pilot study.
Brancato V; Garbino N; Mannelli L; Aiello M; Salvatore M; Franzese M; Cavaliere C
World J Gastroenterol; 2021 Sep; 27(36):6110-6127. PubMed ID: 34629823
[TBL] [Abstract][Full Text] [Related]
23. Dual-region radiomics signature: Integrating primary tumor and lymph node computed tomography features improves survival prediction in esophageal squamous cell cancer.
Lu N; Zhang WJ; Dong L; Chen JY; Zhu YL; Zhang SH; Fu JH; Yin SH; Li ZC; Xie CM
Comput Methods Programs Biomed; 2021 Sep; 208():106287. PubMed ID: 34311416
[TBL] [Abstract][Full Text] [Related]
24. CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: A multicenter study.
Gong J; Zhang W; Huang W; Liao Y; Yin Y; Shi M; Qin W; Zhao L
Radiother Oncol; 2022 Sep; 174():8-15. PubMed ID: 35750106
[TBL] [Abstract][Full Text] [Related]
25. Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy.
Xie C; Yang P; Zhang X; Xu L; Wang X; Li X; Zhang L; Xie R; Yang L; Jing Z; Zhang H; Ding L; Kuang Y; Niu T; Wu S
EBioMedicine; 2019 Jun; 44():289-297. PubMed ID: 31129097
[TBL] [Abstract][Full Text] [Related]
26. Improved Prognosis of Treatment Failure in Cervical Cancer with Nontumor PET/CT Radiomics.
Yusufaly TI; Zou J; Nelson TJ; Williamson CW; Simon A; Singhal M; Liu H; Wong H; Saenz CC; Mayadev J; McHale MT; Yashar CM; Eskander R; Sharabi A; Hoh CK; Obrzut S; Mell LK
J Nucl Med; 2022 Jul; 63(7):1087-1093. PubMed ID: 34711618
[TBL] [Abstract][Full Text] [Related]
27. Model integrating CT-based radiomics and genomics for survival prediction in esophageal cancer patients receiving definitive chemoradiotherapy.
Cui J; Li L; Liu N; Hou W; Dong Y; Yang F; Zhu S; Li J; Yuan S
Biomark Res; 2023 Apr; 11(1):44. PubMed ID: 37095586
[TBL] [Abstract][Full Text] [Related]
28. Prediction of response after chemoradiation for esophageal cancer using a combination of dosimetry and CT radiomics.
Jin X; Zheng X; Chen D; Jin J; Zhu G; Deng X; Han C; Gong C; Zhou Y; Liu C; Xie C
Eur Radiol; 2019 Nov; 29(11):6080-6088. PubMed ID: 31028447
[TBL] [Abstract][Full Text] [Related]
29. Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model.
Cheng X; Zhang Y; Zhu M; Sun R; Liu L; Li X
BMC Med Imaging; 2023 Oct; 23(1):145. PubMed ID: 37779188
[TBL] [Abstract][Full Text] [Related]
30. Contrast-enhanced CT-based radiomic analysis for determining the response to anti-programmed death-1 therapy in esophageal squamous cell carcinoma patients: A pilot study.
Yang Q; Huang H; Zhang G; Weng N; Ou Z; Sun M; Luo H; Zhou X; Gao Y; Wu X
Thorac Cancer; 2023 Nov; 14(33):3266-3274. PubMed ID: 37743537
[TBL] [Abstract][Full Text] [Related]
31. Addition of HER2 and CD44 to
Beukinga RJ; Wang D; Karrenbeld A; Dijksterhuis WPM; Faber H; Burgerhof JGM; Mul VEM; Slart RHJA; Coppes RP; Plukker JTM
Eur Radiol; 2021 May; 31(5):3306-3314. PubMed ID: 33151397
[TBL] [Abstract][Full Text] [Related]
32. Pretreatment CT and
Rishi A; Zhang GG; Yuan Z; Sim AJ; Song EY; Moros EG; Tomaszewski MR; Latifi K; Pimiento JM; Fontaine JP; Mehta R; Harrison LB; Hoffe SE; Frakes JM
J Med Imaging Radiat Oncol; 2021 Feb; 65(1):102-111. PubMed ID: 33258556
[TBL] [Abstract][Full Text] [Related]
33. Application and limitation of radiomics approach to prognostic prediction for lung stereotactic body radiotherapy using breath-hold CT images with random survival forest: A multi-institutional study.
Kakino R; Nakamura M; Mitsuyoshi T; Shintani T; Kokubo M; Negoro Y; Fushiki M; Ogura M; Itasaka S; Yamauchi C; Otsu S; Sakamoto T; Sakamoto M; Araki N; Hirashima H; Adachi T; Matsuo Y; Mizowaki T
Med Phys; 2020 Sep; 47(9):4634-4643. PubMed ID: 32645224
[TBL] [Abstract][Full Text] [Related]
34. Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery.
Qiu Q; Duan J; Deng H; Han Z; Gu J; Yue NJ; Yin Y
Front Oncol; 2020; 10():1398. PubMed ID: 32850451
[No Abstract] [Full Text] [Related]
35. CT radiomic features for predicting resectability of oesophageal squamous cell carcinoma as given by feature analysis: a case control study.
Ou J; Li R; Zeng R; Wu CQ; Chen Y; Chen TW; Zhang XM; Wu L; Jiang Y; Yang JQ; Cao JM; Tang S; Tang MJ; Hu J
Cancer Imaging; 2019 Oct; 19(1):66. PubMed ID: 31619297
[TBL] [Abstract][Full Text] [Related]
36. Computed tomography-based radiomic analysis for predicting pathological response and prognosis after neoadjuvant chemotherapy in patients with locally advanced esophageal cancer.
Oda S; Kuno H; Hiyama T; Sakashita S; Sasaki T; Kobayashi T
Abdom Radiol (NY); 2023 Aug; 48(8):2503-2513. PubMed ID: 37171586
[TBL] [Abstract][Full Text] [Related]
37. The Role of PET-Based Radiomic Features in Predicting Local Control of Esophageal Cancer Treated with Concurrent Chemoradiotherapy.
Xiong J; Yu W; Ma J; Ren Y; Fu X; Zhao J
Sci Rep; 2018 Jul; 8(1):9902. PubMed ID: 29967326
[TBL] [Abstract][Full Text] [Related]
38. Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer.
Piazzese C; Foley K; Whybra P; Hurt C; Crosby T; Spezi E
PLoS One; 2019; 14(11):e0225550. PubMed ID: 31756181
[TBL] [Abstract][Full Text] [Related]
39. CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy.
Yang Z; He B; Zhuang X; Gao X; Wang D; Li M; Lin Z; Luo R
J Radiat Res; 2019 Jul; 60(4):538-545. PubMed ID: 31111948
[TBL] [Abstract][Full Text] [Related]
40. Radiomics and dosiomics for predicting complete response to definitive chemoradiotherapy patients with oesophageal squamous cell cancer using the hybrid institution model.
Kawahara D; Murakami Y; Awane S; Emoto Y; Iwashita K; Kubota H; Sasaki R; Nagata Y
Eur Radiol; 2024 Feb; 34(2):1200-1209. PubMed ID: 37589902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
